CGTX – cognition therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely? [Yahoo! Finance]
Cognition Therapeutics (NASDAQ:CGTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Cognition Therapeutics (NASDAQ:CGTX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 10-Q COGNITION THERAPEUTICS For: Sep 30
Form 8-K COGNITION THERAPEUTICS For: Nov 06
Form SCHEDULE 13D/A COGNITION THERAPEUTICS Filed by: BIOS Memory SPV I, LP
Form 4 COGNITION THERAPEUTICS For: Sep 19 Filed by: Fletcher Aaron G.L.
Form 8-K COGNITION THERAPEUTICS For: Sep 15
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.